馬應龍 (600993.SS)

26.74 +0.04 (+0.15%) 市場開市。 截至 11:22AM CST。

馬應龍

No. 100, Zhoujiawan
Nanhu Lake Wuchang District
Wuhan 430064
China
86 27 8738 9583
https://www.mayinglong.cn

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 2,882

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Youzhang Xia	GM & Director	無	無	1979
Mr. Tao Mao	Finance Director & Accounting Supervisor	無	無	1975
Mr. Ping An Liu	Deputy GM & Director	無	無	1987
Ms. Qian Ma	Deputy GM & Secretary to the Board of Directors	無	無	1982

截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CNY。

描述

Mayinglong Pharmaceutical Group Co., LTD. engages in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. The company products pipeline primarily consists of functional cosmetics, functional care products, functional food, and Chinese herbal medicines, as well as hemorrhoid, gynecological, cough, and skin products; and medical instruments. It is also involved in the retail and wholesale of medical devices and drugs; provision of hospital medical services; and operation of hospitals. The company sells its products through online channels. Mayinglong Pharmaceutical Group Co., LTD. was founded in 1582 and is headquartered in Wuhan, China.

公司管治

截至 無 止，馬應龍 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。